Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients:a nationwide cohort study

MLA

Anna Winther Mogensen, et al. Use of 18F-NaF PET in the Staging of Skeletal Metastases of Newly Diagnosed, High-Risk Prostate Cancer Patients:A Nationwide Cohort Study. June 2022. EBSCOhost, https://doi.org/10.1136/bmjopen-2021-058898.

APA

Anna Winther Mogensen, Lars J Petersen, Christian Torp-Pedersen, Mette Nørgaard, Marie T Pank, & Helle D Zacho. (2022). Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients:a nationwide cohort study. https://doi.org/10.1136/bmjopen-2021-058898

Chicago

Anna Winther Mogensen, Lars J Petersen, Christian Torp-Pedersen, Mette Nørgaard, Marie T Pank, and Helle D Zacho. 2022. “Use of 18F-NaF PET in the Staging of Skeletal Metastases of Newly Diagnosed, High-Risk Prostate Cancer Patients:A Nationwide Cohort Study,” June. doi:10.1136/bmjopen-2021-058898.